In two groups of rats trained to discriminate 0.08 or 0.16 mg/kg of lysergic acid diethylamide (LSD) from saline, pirenperone and ketanserin completely blocked the stimulus effect of LSD. Pizotifen (BC-105) blocked the LSD cue when the training dose was 0.08 mg/kg, but had variable effects in the 0.16 mg/kg of LSD-trained group. The antagonism of the 0.08 mg/kg cue occurred at doses of the antagonists which blocked [3H]spiroperidol labeled 5-HT2 receptors in the frontal cortex in vivo; binding in the striatum was unaffected by the LSD antagonists. However, in doses which produce the LSD cue, neither LSD nor the 5-HT agonist, 5-methoxy-N,N-dimethyltryptamine, which substitutes for LSD, inhibited the binding in either the cortex or the striatum. The results are discussed in relation to the possible neuropharmacological basis for the LSD cue.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0166-4328(85)90090-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing the effects of 5-HT and 5-HT receptor antagonists on DOI-induced head-twitch response in male rats using marker-less deep learning algorithms.
Pharmacol Rep
February 2025
Behavioral Neuroscience and Drug Development, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Article Synopsis
- The study investigates a new, marker-less method using deep learning to track head-twitch responses in rodents, traditionally observed by humans.
- High-speed videos were analyzed with DeepLabCut and SimBA, showing strong agreement with human counts while evaluating the effects of the psychedelic DOI.
- Results confirmed that certain 5-HT receptor antagonists can reduce head-twitch responses, supporting the idea that this behavior is specific to serotonergic activity, and demonstrated the effectiveness of the automated tracking tools for research purposes.
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
Prog Neuropsychopharmacol Biol Psychiatry
December 2022
Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, Canada. Electronic address:
Aim: Psychedelic compounds elicit relief from mental disorders. However, the underpinnings of therapeutic improvement remain poorly understood. Here, we investigated the effects of repeated lysergic acid diethylamide (LSD) on whole-genome DNA methylation and protein expression in the mouse prefrontal cortex (PFC).
View Article and Find Full Text PDFEarly onset effects of single substrate accumulation recapitulate major features of LSD in patient-derived lysosomes.
iScience
July 2021
Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy.
Lysosome functions mainly rely on their ability to either degrade substrates or release them into the extracellular space. Lysosomal storage disorders (LSDs) are commonly characterized by a chronic lysosomal accumulation of different substrates, thereby causing lysosomal dysfunctions and secretion defects. However, the early effects of substrate accumulation on lysosomal homeostasis have not been analyzed so far.
View Article and Find Full Text PDFRe-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats.
Behav Pharmacol
December 2020
Department of Psychology, Western Michigan University, Kalamazoo, Michigan, USA.
Recent discoveries from clinical trials with psychedelic-assisted therapy have led to a resurgence of interest in the psychopharmacology of lysergic acid diethylamide (LSD). Preclinical drug discrimination is an invaluable tool to investigate the neurochemical mechanisms underlying subjective drug effects. The current study extends previous drug discrimination research by including both sexes.
View Article and Find Full Text PDFSerotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
J Psychopharmacol
November 2019
Behavioral Neuroscience and Drug Development, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Purpose: Like other psychedelics, D-lysergic acid diethylamide (LSD) affects numerous serotonin receptors, and according to the current dogma, the 5-HT receptors are considered the main target for its hallucinogenic effects. LSD, however, also displays agonistic activity at the 5-HT receptors, which mediate some of LSD-induced behavioural effects.
Methods: Using male Sprague Dawley rats, we examined the effects of 5-HT and 5-HT receptor antagonists on LSD-induced stimulus control in the two-lever drug discrimination test using a FR10 schedule of reinforcement.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!